Enhancing clipping solutions for durable, long-term patient outcomes
Leading experts shared new data reinforcing TriClip™ TEER’s safety and effectiveness. The session emphasized early intervention benefits, featuring a live-in-a-box case of successful mixed TR treatment. In the mitral segment, polling showed a shift toward treating more RESHAPE-like patients, highlighting the need for timely referrals. Strong engagement showed momentum for earlier TEER.
Related Videos
Poster: Primary MR in the Very Elderly
TRILUMINATE Pivotal - 2-year update EuroPCR 25
bRIGHT 2-year real-world outcomes
Prognosis of TR after MitraClip for MR
Transcatheter Interventions 2022: Breakout
AV VALVES 2023: TR – Multileaflet Valve
Abbott TMTI at PCRLV - recorded cases and more
Mechanical Heart Valve Patient Story: Javier
M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks
AV VALVES 2023: MR – Mixed MR
T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks
T-TEER: echo procedural approach
TRENDING TOPICS
CS Webinar-Aortic valvular disease management
Prognosis of TR after MitraClip for MR
Poster: Primary MR in the Very Elderly